Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | 13 days ago |

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...
Streetwise Reports | October 15, 2019 |

The Notre Dame Fire: Lessons for Gold Investors

The Monday’s fire of Notre Dame Cathedral shocked the world. Since then, the French, the Catholics, and the architecture and art lovers hadn’t been talking about anything else. The precious metals community was less disturbed – even though it tu...
Arkadiusz Sieron | April 18, 2019 |

Revolutionizing Egyptian oil exploration

TAG Oil’s Tech-Driven Breakthrough In the vast expanse of Egypt’s Western Desert, a hidden treasure of oil and gas resources lies in wait, largely untapped until now. The Badr oil field (BED-1) in the Western Desert holds the promisi...
Research | December 19, 2023 |

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. Revive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS) , a company that focuses on repurposing drugs for infectious diseases and rare disorders, is prepari...
Streetwise Reports | June 4, 2020 |

Global Negative Yields Tell A Story Of Shifting Economic Strength

Negative yields are becoming common for many of the world's most mature economies. The process of extending negative yields within these economies suggests that safety is more important than returns and that central banks realize that growth and increases in GDP are more impor...
Chris Vermeulen | August 21, 2019 |

News Flash!

"Never trust anything a banker (broker) tells you."—former billionaire (now millionaire) Here is a news flash: I am sick to death of The Fed, unelected demigods that rarely, if ever, had to meet payroll. I am also completely disgusted with this unholy "Divine Right ...
Streetwise Reports | December 18, 2019 |